Therapeutic Asset Ratings
2,003 results matching 1 filter
129,767 assets · 8,707 sponsors · 3,128 indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
IMMUNOGLOBULIN G 1 (HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .GAMMA.1-CHAIN ANTI-HUMAN ANTIGEN CD 20), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .KAPPA.-CHAIN, DIMER
Therapy Related Acute Myeloid Leukemia And Myelodysplastic Syndrome
M.D. Anderson Cancer Center
P2
B
(60)
Infliximab
Cancer
M.D. Anderson Cancer Center
P2
B
(60)
Inno-206
Metastasis From Malignant Tumor Of Colon
M.D. Anderson Cancer Center
P2
B
(60)
Ipilimumab
B-Cell Non-Hodgkin Lymphoma
M.D. Anderson Cancer Center
P2
B
(60)
Ipilimumab
Primary Peritoneal Carcinoma
M.D. Anderson Cancer Center
P2
B
(60)
Irinotecan
Cervical Squamous Cell Carcinoma
M.D. Anderson Cancer Center
P2
B
(60)
Irinotecan
Recurrent Diffuse Large B-Cell Lymphoma
M.D. Anderson Cancer Center
P2
B
(60)
Irinotecan
Nasopharyngeal Carcinoma
M.D. Anderson Cancer Center
P2
B
(60)
Mesna
Neoplasm
M.D. Anderson Cancer Center
P2
B
(60)
METHOTREXATE
Acute Myeloid Leukemia With BCR-ABL1
M.D. Anderson Cancer Center
P2
B
(60)
Monomethyl Fumarate
Myeloid Neoplasm
M.D. Anderson Cancer Center
P2
B
(60)
Naproxen
Lynch Syndrome
M.D. Anderson Cancer Center
P2
B
(60)
Nivolumab
Uterine Corpus Cancer
M.D. Anderson Cancer Center
P2
B
(60)
Nivolumab
Stage III Renal Pelvis Cancer AJCC v8
M.D. Anderson Cancer Center
P2
B
(60)
Nivolumab
Ureter Cancer
M.D. Anderson Cancer Center
P2
B
(60)
Nivolumab
Urethra Cancer
M.D. Anderson Cancer Center
P2
B
(60)
Nivolumab
Stage IV Ureter Cancer AJCC v8
M.D. Anderson Cancer Center
P2
B
(60)
Nivolumab
Stage IV Urethral Cancer AJCC v8
M.D. Anderson Cancer Center
P2
B
(60)
PEGFILGRASTIM
Burkitt Lymphoma
M.D. Anderson Cancer Center
P2
B
(60)
Ponatinib
Philadelphia Chromosome Positive
M.D. Anderson Cancer Center
P2
B
(60)
Regorafenib
Rectal Cancer
M.D. Anderson Cancer Center
P2
B
(60)
Relatlimab
Nonpapillary Renal Cell Carcinoma
M.D. Anderson Cancer Center
P2
B
(60)
Relatlimab
Ureter Transitional Cell Carcinoma
M.D. Anderson Cancer Center
P2
B
(60)
(+)-VINCRISTINE
Acute Myeloid Leukemia With BCR-ABL1
M.D. Anderson Cancer Center
P2
B
(60)
(+)-VINCRISTINE
Cervical Squamous Cell Carcinoma
M.D. Anderson Cancer Center
P2
B
(60)
Showing 301 to 325 of 2,003 assets
Previous
Page 13 of 81
Next